Method for predicting risk of hypertension associated with anti-angiogenesis therapy

作者: Diether Lambrechts , Paul Delmar , Stefan Scherer , Sanne Lysbet De Haas

DOI:

关键词:

摘要: The invention is concerned with a method of predicting patient's susceptibility to developing hypertension associated an anti-angiogenesis treatment, such as bevacizumab, by determing the genotype KDR gene and/or EGF gene. further relates pharmaceutical composition comprising angiogenesis inhibitor, for treatment patient suffering from cancer based on EGF. reducing risk therapy, in determining

参考文章(41)
Federico Innocenti, Xin Ye, Elisa Cerri, Wanqing Liu, Methods and compositions concerning the vegfr-2 gene (kinase domain receptor, kdr) ,(2008)
George W. Sledge, Bryan P Schneider, Milan Radovich, Vegf polymorphisms and anti-angiogenesis therapy ,(2008)
Christopher L. Sigua, David H. Gelfand, Thomas W. Myers, Methods for coupled high temperatures reverse transcription and polymerase chain reactions ,(1995)
Russell G. Higuchi, Homogeneous methods for nucleic acid amplification and detection Official Gazette of the United States Patent and Trademark Office Patents. ,(1991)
Edward D. Huguenel, Nanibhushan Dattagupta, Peter M.M. Rae, Daniel U. Rabin, Rapid detection of nucleic acid sequences in a sample by labeling the sample ,(1987)